Elevated ratio of urinary metabolites of thromboxane and prostacyclin is associated with adverse cardiovascular events in ADAPT.

Results from prevention trials, including the Alzheimer's Disease Anti-inflammatory Prevention Trial (ADAPT), have fueled discussion about the cardiovascular (CV) risks associated with non-steroidal anti-inflammatory drugs (NSAIDs). We tested the hypotheses that (i) adverse CV events reported a...

Full description

Bibliographic Details

Published in:	PLoS ONE
Main Authors:	Thomas J Montine, Joshua A Sonnen, Ginger Milne, Laura D Baker, John C S Breitner
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2010-02-01
Online Access:	https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0009340&type=printable